Welcome to the official website of 

Kelly Chibale

A distinguished figure and leading expert in African-centric Drug Discovery & Development

About Kelly Chibale

Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) where he holds the Neville Isdell Chair in African-centric Drug Discovery & Development. 

Read More

Latest News

Elected to the United States National Academy of Sciences (NAS) – April 2025

Professor Kelly Chibale has been elected as an international member of the United States National Academy of Sciences (NAS), one of the highest honours in the global scientific community. He is one of only 30 international scientists elected in 2025, and among a small number from Africa ever to receive this recognition.

 

The NAS election acknowledges Professor Chibale’s distinguished and ongoing contributions to original research – particularly in pioneering African-led drug discovery for diseases that disproportionately affect the continent. His work continues to reshape the drug discovery landscape in Africa.

 

Professor Chibale described the honour as both recognition and responsibility, noting his commitment to advancing science policy, entrepreneurship and inclusive innovation. He sees science as a vehicle not only for knowledge but also for economic development and job creation across Africa.

 

This milestone follows his 2024 election to the US National Academy of Medicine, making him one of the elite African scientists recognised by both institutions



Kelly Chibale Elected to United States National Academy of Medicine (NAM)

 

Kelly Chibale, PhD, has been elected as one of the 10 international members of the prestigious United States National Academy of Medicine (NAM). This honour recognises Kelly’s pioneering work in drug discovery and development, particularly in tackling infectious diseases on the African continent.

 

Kelly’s election to NAM highlights his leadership in global health and his exceptional contributions to advancing medical science in Africa. Notably, he has led international teams to discover the first small molecule clinical candidate researched on African soil by an African-led team. This recognition is a testament to Kelly’s unwavering commitment to improving health outcomes and fostering scientific innovation.

 

Kelly extends his heartfelt gratitude to his academic group, H3D team members – past and present – as well as his research collaborators and funders for their invaluable support in achieving this milestone.


Full press release here: https://nam.edu/national-academy-of-medicine-elects-100-new-members-2024/


Catch Up With The Latest On

Kelly Chibale

Find the latest news, interviews, podcasts and developments related to Kelly Chibale here.

NEW ARTICLE: The Guardian

Watch now:


In collaboration with AI2050 and Schmidt Sciences, I’m excited to share this film where I discuss how AI is helping us leapfrog barriers in drug discovery and tailoring medicines for the diverse genetic makeup of African populations.

Media

Professor Kelly Chibale: Drug Discovery Group

Read More

H3D - African Drug Discovery Platform

Listen Podcast
Learn More

Awards & Honours

Kelly Chibale's extraordinary journey is marked by an impressive array of recognitions and accolades that affirm his stellar contributions to science, innovation and leadership.

Fellow of the University of Cape Town

 Royal Society (UK) Africa Prize in 2023

Honorary Doctorate of the Faculty of Science, University of Basel, 2023